EAM
VRTX icon

Erste Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$32.6M Buy
73,903
+5,133
+7% +$2.27M 0.27% 87
2025
Q1
$33.5M Buy
68,770
+2,996
+5% +$1.46M 0.43% 59
2024
Q4
$26.5M Buy
65,774
+2,260
+4% +$912K 0.33% 74
2024
Q3
$29.4M Buy
63,514
+5,208
+9% +$2.41M 0.35% 80
2024
Q2
$27.6M Sell
58,306
-8,392
-13% -$3.97M 0.36% 76
2024
Q1
$27.8M Sell
66,698
-45,233
-40% -$18.9M 0.38% 80
2023
Q4
$45.7M Sell
111,931
-3,294
-3% -$1.35M 0.67% 45
2023
Q3
$40.5M Buy
115,225
+32,150
+39% +$11.3M 0.7% 40
2023
Q2
$28.9M Sell
83,075
-3,655
-4% -$1.27M 0.51% 60
2023
Q1
$27.1M Buy
86,730
+4,600
+6% +$1.44M 0.52% 58
2022
Q4
$23.7M Sell
82,130
-393
-0.5% -$114K 0.5% 58
2022
Q3
$24.2M Sell
82,523
-2,250
-3% -$659K 0.54% 54
2022
Q2
$23.8M Buy
84,773
+773
+0.9% +$217K 0.53% 54
2022
Q1
$21.6M Buy
84,000
+22,800
+37% +$5.85M 0.41% 68
2021
Q4
$13.7M Sell
61,200
-800
-1% -$179K 0.25% 113
2021
Q3
$11.3M Hold
62,000
0.22% 125
2021
Q2
$12.2M Sell
62,000
-7,640
-11% -$1.5M 0.24% 116
2021
Q1
$14.8M Hold
69,640
0.36% 83
2020
Q4
$16.3M Buy
69,640
+7,738
+13% +$1.81M 0.45% 68
2020
Q3
$16.7M Sell
61,902
-6,748
-10% -$1.82M 0.57% 53
2020
Q2
$19.6M Sell
68,650
-22,750
-25% -$6.49M 0.78% 35
2020
Q1
$21.2M Buy
91,400
+9,500
+12% +$2.2M 1.23% 16
2019
Q4
$18.1M Sell
81,900
-130,000
-61% -$28.7M 0.8% 29
2019
Q3
$35.7M Sell
211,900
-9,100
-4% -$1.53M 1.9% 4
2019
Q2
$40.1M Buy
221,000
+18,300
+9% +$3.32M 2.13% 4
2019
Q1
$37.2M Sell
202,700
-16,000
-7% -$2.94M 2.08% 6
2018
Q4
$35.4M Buy
+218,700
New +$35.4M 2.38% 4